Nori D, Hilaris B S, Stanimir G, Lewis J L
Int J Radiat Oncol Biol Phys. 1983 Oct;9(10):1471-5. doi: 10.1016/0360-3016(83)90320-6.
Primary carcinoma of the vagina is rare, constituting only 1 to 2% of all neoplasms arising in the female genital tract. From 1950-1974, 36 patients with carcinoma of the vagina were treated with radiation at Memorial Sloan-Kettering Cancer Center (MSKCC); 35 (96%) had epidermoid carcinoma and one patient (4%) had adenocarcinoma. These patients were staged according to FIGO. Fourteen patients (39%) were Stage I; six patients (17%) were Stage II; three patients (8%) were Stage III; and 13 patients (36%) were Stage IV. Nine patients (25%) were treated with external radiation and interstitial implant; seven patients (20%) were treated with interstitial implant alone; nine patients (25%) were treated with external radiation alone and 11 patients (30%) with external radiation and intracavitary radiation. The five year NED survival was 71% in Stage I, 66% in Stage II, 33% in Stage III and 0% in Stage IV. This paper discusses radiotherapy management of primary carcinoma of the vagina.
原发性阴道癌较为罕见,仅占女性生殖道所有肿瘤的1%至2%。1950年至1974年期间,纪念斯隆凯特琳癌症中心(MSKCC)对36例阴道癌患者进行了放射治疗;其中35例(96%)为表皮样癌,1例(4%)为腺癌。这些患者根据国际妇产科联盟(FIGO)进行分期。14例患者(39%)为I期;6例患者(17%)为II期;3例患者(8%)为III期;13例患者(36%)为IV期。9例患者(25%)接受了外照射和组织间插植治疗;7例患者(20%)仅接受了组织间插植治疗;9例患者(25%)仅接受了外照射治疗,11例患者(30%)接受了外照射和腔内照射治疗。I期患者的五年无疾病生存(NED)率为71%,II期为66%,III期为33%,IV期为0%。本文讨论原发性阴道癌的放射治疗管理。